Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 7, 2022
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
[ Fri, Jan 07th 2022
] - WOPRAI
Whit Mayo Maintained (THC) at Hold with Increased Target to $88 on, Jan 7th, 2022
Whit Mayo of SVB Leerink, Maintained "Tenet Healthcare Corporation" (THC) at Hold with Increased Target from $78 to $88 on, Jan 7th, 2022.
Whit has made no other calls on THC in the last 4 months.
There are 6 other peers that have a rating on THC. Out of the 6 peers that are also analyzing THC, 2 agree with Whit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $90 on, Wednesday, January 5th, 2022
- Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021
These are the ratings of the 4 analyists that currently disagree with Whit
- Sarah James of "Barclays" Maintained at Buy with Increased Target to $87 on, Tuesday, December 21st, 2021
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021
